Evidence map›Paper›PMID 39912682›Full record

ArticleMicrobiology spectrum2025

Evaluation of the LDBio ICT IgG/IgM lateral flow assay versus the Bordier Elisa assay for the diagnosis of chronic pulmonary aspergillosis in Nigeria.

O J Balogun, R O Oladele, O O E Ajibola, A A Davies, T A Fashanu, A O Nwosu, B E Ekeng, J P Gangneux

Abstract readComparative StudyEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Performance of the LDBioMicrobiology spectrum · 2026
    Article
  2. Diagnostic performance ofJournal of thoracic disease · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

O J BalogunDepartment of Biomedical Engineering, University of Lagos, Lagos, Nigeria.ORCID 0000-0002-7329-8448
R O OladeleMedical Mycology Society of Nigeria, Lagos, Nigeria.
O O E AjibolaDepartment of Systems Engineering, Faculty of Engineering, University of Lagos, Lagos, Nigeria.
A A DaviesMedical Mycology Society of Nigeria, Lagos, Nigeria.
T A FashanuDepartment of Systems Engineering, Faculty of Engineering, University of Lagos, Lagos, Nigeria.
A O NwosuMedical Mycology Society of Nigeria, Lagos, Nigeria.
B E EkengMedical Mycology Society of Nigeria, Lagos, Nigeria.
J P GangneuxCentre National de Référence des Mycoses et Antifongiques LA-AspC Aspergilloses Chroniques, European Excellence Center for Medical Mycology (ECMM EC), Centre Hospitalier Universitaire de Rennes, Rennes, France.ORCID 0000-0002-4974-5607

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The detection of anti-

Indexed as

Antibodies, FungalImmunoglobulin GImmunoglobulin MPulmonary AspergillosisAdultAspergillusChronic DiseaseEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedNigeriaPoint-of-Care SystemsPoint-of-Care TestingSensitivity and SpecificityAntibodies, FungalImmunoglobulin GImmunoglobulin MantibodiesAspergillus flavusAspergillus fumigatuschronic pulmonary aspergillosispoint-of-care diagnosis

Identifiers

PMID39912682
PMCPMC11878091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.